HTG Molecular Diagnostics Inc
HTGM
Get informed when a big investor buys or sells
+ FollowMarket Cap$106.28M
Close$
Share Statistics
| Market cap | $106.28 Million |
|---|---|
| Enterprise Value | $107.26 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.24 |
| Beta | 0.99 |
| Outstanding Shares | 221,408,200 |
Return
| Return on Equity | -4246.92% |
|---|---|
| Return on Assets | -185.46% |
| Return on Invested Capital | -460.72% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 17.26 |
| Enterprise Value to EBIT | -5.41 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 8.39 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About HTG Molecular Diagnostics, Inc.
53 employees
CEO: John L. Lubniewski HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables; and software that automate sample processing and profiles various molecular targets. Its marketed mo...